Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

CENTERSPACE (CSR) Stock Forecast 2025 - AI Price Prediction & Analysis

CENTERSPACE (CSR) AI Stock Price Forecast & Investment Analysis

CENTERSPACE Stock Price Chart and Technical Analysis

Loading CENTERSPACE interactive price chart and technical analysis...

CENTERSPACE (CSR) - Comprehensive Stock Analysis & Investment Research

Deep dive into CENTERSPACE's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about CENTERSPACE, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For CENTERSPACE: CENTERSPACE operates in the Real Estate & Construction sector, making it an emerging small-cap investment.

CENTERSPACE (Stock Symbol: CSR) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

The organization employs approximately 177 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing CENTERSPACE's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CENTERSPACE: With $267M in annual revenue and -5.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $267 million generating a -5.6% net profit margin .

Market Capitalization: $1119 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -1.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for CENTERSPACE stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For CENTERSPACE: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for CENTERSPACE stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: CENTERSPACE's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For CENTERSPACE: Strong free cash flow generation demonstrates developing operational efficiency.

CENTERSPACE strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $81 million annually, complemented by impressive -12.1% year-over-year cash flow growth.

The company maintains a healthy -1.7% gross margin, indicating strong pricing power and operational efficiency.

CENTERSPACE (CSR) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for CENTERSPACE stock analysis.

Loading CENTERSPACE comprehensive fundamental analysis and insider trading data...

Deep dive into CENTERSPACE's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if CENTERSPACE stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For CENTERSPACE: With a P/E ratio of -74.60, the market sees the stock as potentially undervalued.

P/E Ratio -74.60x
P/B Ratio 1.49x
Market Cap $1119M
Dividend Yield 5.10%
EPS $-1.80
Book Value/Share $44.83
Revenue/Share $15.94
FCF/Share $4.87
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently CENTERSPACE converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For CENTERSPACE: An ROE of -1.7% indicates room for improvement in shareholder value creation.

ROE -1.7%
ROA -0.6%
ROIC 1.5%
Gross Margin -1.7%
Operating Margin 6.2%
Net Margin -5.6%
EBT Margin -3.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess CENTERSPACE's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For CENTERSPACE: A current ratio of 0.31 suggests potential liquidity concerns.

Current Ratio 0.31x
Quick Ratio 0.26x
D/E Ratio 1.23x
Financial Leverage 2.79x
Interest Coverage 0.8x
Working Capital $-11M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal CENTERSPACE's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For CENTERSPACE: Free cash flow of $81M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $81M
Free Cash Flow $81M
Capital Spending $-142M
OCF Growth YoY -12.1%
FCF Growth YoY -12.1%
FCF/Sales 37.5%
CapEx/Sales 58.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively CENTERSPACE uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For CENTERSPACE: An asset turnover of 0.12x suggests room for improvement in asset utilization.

Asset Turnover 0.12x
Receivables Turnover 215.8x
Fixed Assets Turnover 66.8x
Days Sales Outstanding 2 days
Understanding Financial Statement Data

What these metrics mean: Key figures from CENTERSPACE's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For CENTERSPACE: With annual revenue of $267M, CENTERSPACE demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $267M
Net Income $5M
SG&A Expense $12M
Cost of Goods Sold $9M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 1%
Cash & Short-term Investments 1%
Total Liabilities 53%
Short-term Debt 2%
Accounts Receivable 3%
Dividend & Shareholder Information
Dividends Per Share $3.04
Payout Ratio -0.9%
Shares Outstanding 17M
Growth Metrics (YoY)
EPS Growth -2.5%

Latest CENTERSPACE Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting CENTERSPACE (CSR) stock price and investment outlook.

, source: None

Centerspace, an apartment owner and operator with about 13,000 units, is exploring options to boost its financial performance ...

, source: Nasdaq

Centerspace (NYSE:CSR) is gearing up to announce its quarterly earnings on Monday, 2024-10-28. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

CENTERSPACE Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of CENTERSPACE against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1154M 13.0x 1.0x
ABR Unlock Forecast - 30 Days FREE Trial $1711M 10.5x 0.6x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3412M 16.4x 1.1x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3392M 16.2x 1.1x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4347M 20.4x 1.5x
ACR Unlock Forecast - 30 Days FREE Trial $158M 6.3x 0.4x
ACRE Unlock Forecast - 30 Days FREE Trial $263M 8.5x 0.5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $186M 8.2x 0.4x
ACR-PD Unlock Forecast - 30 Days FREE Trial $163M 7.2x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $8360M 44.4x 1.4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $2015M 10.7x 0.3x
AGNC Unlock Forecast - 30 Days FREE Trial $10813M 27.8x 0.9x
AGNCL Unlock Forecast - 30 Days FREE Trial $26217M 68.0x 2.3x
AGNCM Unlock Forecast - 30 Days FREE Trial $26324M 67.7x 2.3x
AGNCN Unlock Forecast - 30 Days FREE Trial $27204M 70.1x 2.4x
AGNCO Unlock Forecast - 30 Days FREE Trial $27064M 69.4x 2.4x
AGNCP Unlock Forecast - 30 Days FREE Trial $26747M 68.3x 2.3x
AHR Unlock Forecast - 30 Days FREE Trial $8062M x 3.0x
AHT Unlock Forecast - 30 Days FREE Trial $23M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $123M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $85M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $95M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $87M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $87M x x
AIV Unlock Forecast - 30 Days FREE Trial $789M -6.0x 12.7x
AKR Unlock Forecast - 30 Days FREE Trial $2564M 470.2x 1.1x
ALEX Unlock Forecast - 30 Days FREE Trial $1125M 15.9x 1.1x
ALX Unlock Forecast - 30 Days FREE Trial $1091M 32.0x 8.5x
AMH Unlock Forecast - 30 Days FREE Trial $11726M 39.2x 1.6x
AMH-PG Unlock Forecast - 30 Days FREE Trial $8553M x 1.2x
AMH-PH Unlock Forecast - 30 Days FREE Trial $8910M x 1.2x
AMT Unlock Forecast - 30 Days FREE Trial $84527M 68.9x 21.4x
APLE Unlock Forecast - 30 Days FREE Trial $2702M 15.3x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $8430M 55.8x 0.5x
ARI Unlock Forecast - 30 Days FREE Trial $1353M -9.0x 0.7x
ARR Unlock Forecast - 30 Days FREE Trial $1841M 27.6x 0.9x
ARR-PC Unlock Forecast - 30 Days FREE Trial $2433M x 1.1x
AVB Unlock Forecast - 30 Days FREE Trial $25058M 23.4x 2.1x
BDN Unlock Forecast - 30 Days FREE Trial $596M -5.2x 0.7x
BFS Unlock Forecast - 30 Days FREE Trial $741M 17.7x 2.3x
BFS-PD Unlock Forecast - 30 Days FREE Trial $501M 12.7x 1.6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $511M 13.1x 1.6x
BHM Unlock Forecast - 30 Days FREE Trial $35M 15.0x 0.3x
BHR Unlock Forecast - 30 Days FREE Trial $185M -3.1x 0.9x
BHR-PB Unlock Forecast - 30 Days FREE Trial $1015M x 4.8x
BHR-PD Unlock Forecast - 30 Days FREE Trial $1357M x 6.4x
BMNM Unlock Forecast - 30 Days FREE Trial $20M x 0.9x
BNL Unlock Forecast - 30 Days FREE Trial $3419M 35.8x 1.2x
BRSP Unlock Forecast - 30 Days FREE Trial $696M -6.6x 0.7x
BRT Unlock Forecast - 30 Days FREE Trial $253M -37.6x 1.4x
BRX Unlock Forecast - 30 Days FREE Trial $7925M 25.5x 2.7x
BXMT Unlock Forecast - 30 Days FREE Trial $3133M -17.4x 0.9x
BXP Unlock Forecast - 30 Days FREE Trial $10990M 2366.0x 2.2x
CBL Unlock Forecast - 30 Days FREE Trial $988M 13.8x 2.8x
CCI Unlock Forecast - 30 Days FREE Trial $39607M 36.6x 5.6x
CDP Unlock Forecast - 30 Days FREE Trial $3357M 21.2x 2.2x
CDR-PB Unlock Forecast - 30 Days FREE Trial $250M 46.0x 42.8x
CDR-PC Unlock Forecast - 30 Days FREE Trial $222M 41.3x 38.0x
CHCT Unlock Forecast - 30 Days FREE Trial $413M -220.9x 1.0x
CHMI Unlock Forecast - 30 Days FREE Trial $86M -9.3x 0.4x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $790M x 3.4x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $873M x 3.7x
CHTH Unlock Forecast - 30 Days FREE Trial $596M x 0.9x
CIM Unlock Forecast - 30 Days FREE Trial $964M 5.5x 0.4x
CIMN Unlock Forecast - 30 Days FREE Trial $2039M 10.7x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2048M 10.8x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1815M 9.3x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $1977M 10.1x 0.8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1831M 9.5x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1974M 10.1x 0.8x
CIO Unlock Forecast - 30 Days FREE Trial $278M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $999M x 1.6x
CLDT Unlock Forecast - 30 Days FREE Trial $316M 33.9x 0.4x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $958M 108.6x 1.3x
CLPR Unlock Forecast - 30 Days FREE Trial $59M -10.4x -20.5x
CMCT Unlock Forecast - 30 Days FREE Trial $7M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $1452M x 0.8x
COLD Unlock Forecast - 30 Days FREE Trial $2962M -26.5x 1.0x
CPT Unlock Forecast - 30 Days FREE Trial $10870M 72.1x 2.4x
CSR Unlock Forecast - 30 Days FREE Trial $1119M -74.6x 1.5x
CTO Unlock Forecast - 30 Days FREE Trial $564M 41.8x 1.0x
CTO-PA Unlock Forecast - 30 Days FREE Trial $690M x 1.2x
CTRE Unlock Forecast - 30 Days FREE Trial $8139M 31.9x 2.0x
CUBE Unlock Forecast - 30 Days FREE Trial $8177M 25.7x 2.9x
CUZ Unlock Forecast - 30 Days FREE Trial $4224M 74.6x 0.9x
CXW Unlock Forecast - 30 Days FREE Trial $1766M 19.4x 1.2x
DEA Unlock Forecast - 30 Days FREE Trial $956M 65.3x 0.7x
DEI Unlock Forecast - 30 Days FREE Trial $1952M 59.3x 1.0x
DHC Unlock Forecast - 30 Days FREE Trial $1092M -1.7x 0.7x
DHCNI Unlock Forecast - 30 Days FREE Trial $4109M -10.4x 2.4x
DLR Unlock Forecast - 30 Days FREE Trial $54646M 43.2x 2.4x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $7585M 5.6x 0.3x
DLR-PK Unlock Forecast - 30 Days FREE Trial $8260M 6.0x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $7312M 5.5x 0.3x
DOC Unlock Forecast - 30 Days FREE Trial $12238M 78.3x 1.6x
DRH Unlock Forecast - 30 Days FREE Trial $1788M 23.6x 1.1x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5149M 76.7x 3.3x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1954M 25.7x 3.4x
DX-PC Unlock Forecast - 30 Days FREE Trial $3758M 48.9x 6.5x
EARN Unlock Forecast - 30 Days FREE Trial $193M -11.6x 0.8x
EGP Unlock Forecast - 30 Days FREE Trial $9462M 38.5x 2.7x
ELME Unlock Forecast - 30 Days FREE Trial $1478M -114.5x 1.6x
ELS Unlock Forecast - 30 Days FREE Trial $11893M 23.6x 6.8x
EPR Unlock Forecast - 30 Days FREE Trial $3913M 22.9x 1.9x
EPR-PC Unlock Forecast - 30 Days FREE Trial $1744M 10.3x 0.8x
EPR-PE Unlock Forecast - 30 Days FREE Trial $2333M 13.1x 1.1x
EPR-PG Unlock Forecast - 30 Days FREE Trial $1546M 8.8x 0.7x
EPRT Unlock Forecast - 30 Days FREE Trial $6085M 25.7x 1.6x
EQIX Unlock Forecast - 30 Days FREE Trial $75121M 81.9x 5.3x
EQR Unlock Forecast - 30 Days FREE Trial $22429M 28.0x 2.0x
ESBA Unlock Forecast - 30 Days FREE Trial $1828M 46.6x x
ESRT Unlock Forecast - 30 Days FREE Trial $1825M 83.1x 1.8x
ESS Unlock Forecast - 30 Days FREE Trial $16399M 21.3x 2.9x
EXR Unlock Forecast - 30 Days FREE Trial $27469M 32.9x 2.0x
FBRT Unlock Forecast - 30 Days FREE Trial $811M 8.2x 0.6x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1748M 16.8x 1.2x
FCPT Unlock Forecast - 30 Days FREE Trial $2483M 23.6x 1.6x
FISK Unlock Forecast - 30 Days FREE Trial $1876M x x
FPI Unlock Forecast - 30 Days FREE Trial $408M 6.5x 407521.9x
FR Unlock Forecast - 30 Days FREE Trial $7282M 31.3x 2.8x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $8296M 25.4x 2.6x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1755M 5.3x 0.6x
FSP Unlock Forecast - 30 Days FREE Trial $109M -1.9x 0.2x
FVR Unlock Forecast - 30 Days FREE Trial $294M x 0.8x
GEDC Unlock Forecast - 30 Days FREE Trial $10M x x
GIPR Unlock Forecast - 30 Days FREE Trial $5M -0.8x 17.0x
GLPI Unlock Forecast - 30 Days FREE Trial $12152M 17.7x 2.7x
GMRE Unlock Forecast - 30 Days FREE Trial $421M 209.0x 0.9x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $322M 162.4x 0.7x
GNL Unlock Forecast - 30 Days FREE Trial $1747M -4.5x 1.0x
GNL-PA Unlock Forecast - 30 Days FREE Trial $5024M x 3.0x
GNL-PB Unlock Forecast - 30 Days FREE Trial $4945M x 2.9x
GNL-PD Unlock Forecast - 30 Days FREE Trial $5280M x 3.1x
GNL-PE Unlock Forecast - 30 Days FREE Trial $5024M x 3.0x
GPMT Unlock Forecast - 30 Days FREE Trial $130M -0.9x 0.2x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $931M x 1.6x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2542M x 2.9x
HHH Unlock Forecast - 30 Days FREE Trial $4933M 68.5x 1.3x
HIW Unlock Forecast - 30 Days FREE Trial $3013M 24.4x 1.3x
HLTC Unlock Forecast - 30 Days FREE Trial $212M x 0.3x
HST Unlock Forecast - 30 Days FREE Trial $11691M 17.3x 1.8x
ICRP Unlock Forecast - 30 Days FREE Trial $85M 7.5x 0.4x
ICR-PA Unlock Forecast - 30 Days FREE Trial $200M 17.4x 0.9x
IHT Unlock Forecast - 30 Days FREE Trial $13M -57.7x 3.2x
ILPT Unlock Forecast - 30 Days FREE Trial $336M -2.3x 0.7x
IMPM Unlock Forecast - 30 Days FREE Trial $3M x x
INN Unlock Forecast - 30 Days FREE Trial $537M 68.0x 0.6x
INN-PE Unlock Forecast - 30 Days FREE Trial $2083M 241.6x 2.4x
INN-PF Unlock Forecast - 30 Days FREE Trial $2186M 369.2x 2.5x
INRE Unlock Forecast - 30 Days FREE Trial $397M x 1.2x
IOR Unlock Forecast - 30 Days FREE Trial $73M 16.8x 0.6x
IRM Unlock Forecast - 30 Days FREE Trial $25620M 202.7x -41.7x
IRT Unlock Forecast - 30 Days FREE Trial $3945M 137.0x 1.1x
IVR Unlock Forecast - 30 Days FREE Trial $543M 11.8x 0.7x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1751M 40.1x 2.3x
IVT Unlock Forecast - 30 Days FREE Trial $2144M 20.0x 1.2x
JBGS Unlock Forecast - 30 Days FREE Trial $1076M -11.3x 0.6x
KBSR Unlock Forecast - 30 Days FREE Trial $55M x 0.3x
KIM Unlock Forecast - 30 Days FREE Trial $13551M 25.3x 1.3x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14004M 23.8x 1.3x
KIM-PM Unlock Forecast - 30 Days FREE Trial $14153M 24.5x 1.4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $39934M 65.8x 3.8x
KRC Unlock Forecast - 30 Days FREE Trial $4911M 22.1x 0.9x
KREF Unlock Forecast - 30 Days FREE Trial $533M 952.5x 0.4x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1255M x 1.0x
KRG Unlock Forecast - 30 Days FREE Trial $4783M 27.0x 1.5x
LADR Unlock Forecast - 30 Days FREE Trial $1317M 15.1x 0.9x
LAMR Unlock Forecast - 30 Days FREE Trial $12956M 28.5x 12.6x
LAND Unlock Forecast - 30 Days FREE Trial $327M -54.4x 0.5x
LANDM Unlock Forecast - 30 Days FREE Trial $908M -119.7x 1.4x
LANDO Unlock Forecast - 30 Days FREE Trial $717M -104.0x 1.1x
LANDP Unlock Forecast - 30 Days FREE Trial $709M -103.5x 1.1x
LFT Unlock Forecast - 30 Days FREE Trial $78M 6.5x 0.3x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1072M 74.5x 4.7x
LINE Unlock Forecast - 30 Days FREE Trial $7572M x 0.9x
LOAN Unlock Forecast - 30 Days FREE Trial $53M 10.9x 1.2x
LTC Unlock Forecast - 30 Days FREE Trial $1726M 19.6x 1.8x
LXP Unlock Forecast - 30 Days FREE Trial $13599M 32.3x 6.6x
LXP-PC Unlock Forecast - 30 Days FREE Trial $13960M 162.3x 6.8x
MAA Unlock Forecast - 30 Days FREE Trial $15201M 27.5x 2.6x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6199M 11.4x 1.1x
MAC Unlock Forecast - 30 Days FREE Trial $4157M -64.7x 1.7x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8.9x 1.5x
MDV Unlock Forecast - 30 Days FREE Trial $163M -24.6x 1.0x
MDV-PA Unlock Forecast - 30 Days FREE Trial $290M x 1.8x
MFA Unlock Forecast - 30 Days FREE Trial $920M 7.3x 0.5x
MFAN Unlock Forecast - 30 Days FREE Trial $2548M 20.2x 1.4x
MFAO Unlock Forecast - 30 Days FREE Trial $2575M 20.4x 1.4x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2123M 16.6x 1.2x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2437M 19.1x 1.3x
MITN Unlock Forecast - 30 Days FREE Trial $798M 16.3x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $797M 16.3x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $244M 4.7x 0.4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $715M 14.4x 1.3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $694M 13.6x 1.2x
MITT-PC Unlock Forecast - 30 Days FREE Trial $802M 16.1x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $8M x 0.2x
MPW Unlock Forecast - 30 Days FREE Trial $3030M -1.3x 0.7x
NHI Unlock Forecast - 30 Days FREE Trial $3556M 24.0x 2.4x
NHPAP Unlock Forecast - 30 Days FREE Trial $525M x 0.8x
NHPBP Unlock Forecast - 30 Days FREE Trial $510M x 0.8x
NLCP Unlock Forecast - 30 Days FREE Trial $259M 10.4x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $431M x 1.0x
NLY Unlock Forecast - 30 Days FREE Trial $14711M -22.9x 1.0x
NLY-PF Unlock Forecast - 30 Days FREE Trial $17394M x 1.2x
NLY-PG Unlock Forecast - 30 Days FREE Trial $17203M x 1.2x
NLY-PI Unlock Forecast - 30 Days FREE Trial $17394M x 1.2x
NNN Unlock Forecast - 30 Days FREE Trial $7713M 20.3x 1.8x
NREF Unlock Forecast - 30 Days FREE Trial $242M 2.8x 1.8x
NREF-PA Unlock Forecast - 30 Days FREE Trial $421M 4.8x 3.1x
NSA Unlock Forecast - 30 Days FREE Trial $2202M 26.1x 2.3x
NSA-PA Unlock Forecast - 30 Days FREE Trial $1672M x 1.7x
NSA-PB Unlock Forecast - 30 Days FREE Trial $1650M x 1.7x
NTST Unlock Forecast - 30 Days FREE Trial $1534M 1247.7x 1.2x
NXDT Unlock Forecast - 30 Days FREE Trial $139M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $655M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $781M 16.6x 2.4x
NYC Unlock Forecast - 30 Days FREE Trial $21M -0.1x 0.6x
O Unlock Forecast - 30 Days FREE Trial $52167M 60.1x 1.3x
OGCP Unlock Forecast - 30 Days FREE Trial $1892M x x
OLP Unlock Forecast - 30 Days FREE Trial $423M 25.4x 1.4x
ONL Unlock Forecast - 30 Days FREE Trial $135M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $1060M 148.1x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $3696M 27.8x 6.8x
PCH Unlock Forecast - 30 Days FREE Trial $2975M 78.9x 1.6x
PCOK Unlock Forecast - 30 Days FREE Trial $5M x 0.2x
PEB Unlock Forecast - 30 Days FREE Trial $1209M -21.5x 0.5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2148M x 0.9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2152M x 0.9x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2154M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $1982M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $4341M 53.2x 1.9x
PGRE Unlock Forecast - 30 Days FREE Trial $1453M -5.8x 0.5x
PINE Unlock Forecast - 30 Days FREE Trial $235M 169.3x 1.1x
PKST Unlock Forecast - 30 Days FREE Trial $504M -3.7x 0.7x
PLD Unlock Forecast - 30 Days FREE Trial $113668M 33.8x 2.2x
PLDGP Unlock Forecast - 30 Days FREE Trial $50612M 15.0x 1.0x
PMT Unlock Forecast - 30 Days FREE Trial $1075M 10.4x 0.6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2111M 19.7x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2106M 19.8x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1659M 15.6x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2232M 21.2x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2205M 21.2x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2236M 21.1x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $46822M 29.8x 5.0x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3826M 2.2x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3736M 2.1x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4146M 2.4x 0.5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3497M 2.1x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3381M 2.0x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3416M 2.0x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3314M 1.9x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $2954M 1.7x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2794M 1.6x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2797M 1.6x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2823M 1.7x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2829M 1.6x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2890M 1.6x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $2952M 1.7x 0.3x
PSTL Unlock Forecast - 30 Days FREE Trial $368M 147.2x 1.3x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.4x
PW-PA Unlock Forecast - 30 Days FREE Trial $15M x 2.4x
RC Unlock Forecast - 30 Days FREE Trial $381M -13.0x 0.2x
RCB Unlock Forecast - 30 Days FREE Trial $3973M -44.3x 2.2x
RCC Unlock Forecast - 30 Days FREE Trial $4028M -45.2x 2.3x
RCD Unlock Forecast - 30 Days FREE Trial $3844M x 2.2x
RC-PC Unlock Forecast - 30 Days FREE Trial $2426M x 1.4x
RC-PE Unlock Forecast - 30 Days FREE Trial $2308M x 1.3x
REFI Unlock Forecast - 30 Days FREE Trial $255M 8.1x 0.8x
REG Unlock Forecast - 30 Days FREE Trial $12590M 61.0x 1.9x
REGCO Unlock Forecast - 30 Days FREE Trial $4191M x 0.6x
REGCP Unlock Forecast - 30 Days FREE Trial $4341M x 0.6x
REXR Unlock Forecast - 30 Days FREE Trial $9359M 29.0x 1.1x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5213M 17.1x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5004M 15.3x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $5749M 21.0x 7.6x
RITM Unlock Forecast - 30 Days FREE Trial $6007M 7.2x 0.7x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14049M 16.9x 1.7x
RITM-PB Unlock Forecast - 30 Days FREE Trial $13921M 16.8x 1.6x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13633M 16.4x 1.6x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13606M 16.3x 1.6x
RLJ Unlock Forecast - 30 Days FREE Trial $1112M 18.2x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3794M 65.8x 1.7x
RPT Unlock Forecast - 30 Days FREE Trial $113M -0.8x 0.4x
RPT-PC Unlock Forecast - 30 Days FREE Trial $1136M x 3.9x
RWT Unlock Forecast - 30 Days FREE Trial $648M 31.3x 0.7x
RWTN Unlock Forecast - 30 Days FREE Trial $3169M x 3.2x
RWTO Unlock Forecast - 30 Days FREE Trial $3160M x 3.2x
RWTP Unlock Forecast - 30 Days FREE Trial $3152M x 3.2x
RWT-PA Unlock Forecast - 30 Days FREE Trial $3052M x 3.1x
SACH Unlock Forecast - 30 Days FREE Trial $50M 21.3x 0.3x
SACH-PA Unlock Forecast - 30 Days FREE Trial $873M x 5.0x
SAFE Unlock Forecast - 30 Days FREE Trial $931M 11.0x 0.4x
SBAC Unlock Forecast - 30 Days FREE Trial $20937M 24.0x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4640M 23.8x 1.6x
SCCC Unlock Forecast - 30 Days FREE Trial $1192M 361.5x 6.8x
SCCD Unlock Forecast - 30 Days FREE Trial $1143M 304.5x 6.5x
SCCE Unlock Forecast - 30 Days FREE Trial $1097M 304.8x 6.3x
SCCF Unlock Forecast - 30 Days FREE Trial $1098M 279.9x 6.3x
SCCG Unlock Forecast - 30 Days FREE Trial $1107M 325.2x 6.3x
SELF Unlock Forecast - 30 Days FREE Trial $58M 22.8x 1.2x
SEVN Unlock Forecast - 30 Days FREE Trial $132M 10.5x 0.5x
SILA Unlock Forecast - 30 Days FREE Trial $1302M x 1.0x
SITC Unlock Forecast - 30 Days FREE Trial $359M 1.3x 1.2x
SKT Unlock Forecast - 30 Days FREE Trial $3757M 38.7x 5.3x
SLG Unlock Forecast - 30 Days FREE Trial $3120M -33.2x 0.8x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1507M x 0.4x
SMA Unlock Forecast - 30 Days FREE Trial $971M x 0.8x
SOHO Unlock Forecast - 30 Days FREE Trial $44M -1.4x 1.2x
SOHOB Unlock Forecast - 30 Days FREE Trial $351M -21.4x 9.5x
SOHON Unlock Forecast - 30 Days FREE Trial $319M -21.8x 8.7x
SOHOO Unlock Forecast - 30 Days FREE Trial $358M -25.6x 9.7x
SPG Unlock Forecast - 30 Days FREE Trial $58800M 23.1x 25.0x
SPG-PJ Unlock Forecast - 30 Days FREE Trial $17617M x 7.5x
SQFT Unlock Forecast - 30 Days FREE Trial $42M 1.2x 1.2x
SQFTP Unlock Forecast - 30 Days FREE Trial $138M 24.7x 3.9x
STAG Unlock Forecast - 30 Days FREE Trial $7132M 30.9x 2.1x
STLY Unlock Forecast - 30 Days FREE Trial $26M 37.8x 0.6x
STRW Unlock Forecast - 30 Days FREE Trial $154M 25.5x 10.8x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $6510M 17.2x 1.0x
SUI Unlock Forecast - 30 Days FREE Trial $15515M 12.2x 2.2x
SUNS Unlock Forecast - 30 Days FREE Trial $131M 13.4x 0.7x
SVC Unlock Forecast - 30 Days FREE Trial $262M -2.2x 0.4x
TCI Unlock Forecast - 30 Days FREE Trial $392M 58.9x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $202M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $570M x 3.6x
TRTX Unlock Forecast - 30 Days FREE Trial $685M 10.6x 0.6x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1400M 20.7x 1.3x
TWO Unlock Forecast - 30 Days FREE Trial $993M -55.6x 0.4x
TWOD Unlock Forecast - 30 Days FREE Trial $2654M x 1.1x
TWO-PA Unlock Forecast - 30 Days FREE Trial $2463M x 1.0x
TWO-PB Unlock Forecast - 30 Days FREE Trial $2399M x 1.0x
TWO-PC Unlock Forecast - 30 Days FREE Trial $2502M x 1.0x
UDR Unlock Forecast - 30 Days FREE Trial $11428M 91.4x 3.5x
UHT Unlock Forecast - 30 Days FREE Trial $548M 28.2x 3.5x
UMH Unlock Forecast - 30 Days FREE Trial $1259M 40.8x 1.4x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1910M 63.1x 2.1x
VICI Unlock Forecast - 30 Days FREE Trial $31156M 12.1x 1.1x
VNO Unlock Forecast - 30 Days FREE Trial $6536M 8.6x 1.1x
VNO-PL Unlock Forecast - 30 Days FREE Trial $3412M 4.0x 0.6x
VNO-PM Unlock Forecast - 30 Days FREE Trial $3341M 4.0x 0.6x
VNO-PN Unlock Forecast - 30 Days FREE Trial $3347M 4.0x 0.6x
VNO-PO Unlock Forecast - 30 Days FREE Trial $2804M 3.3x 0.5x
VNORP Unlock Forecast - 30 Days FREE Trial $12772M 17.9x 2.1x
VRE Unlock Forecast - 30 Days FREE Trial $1410M 22.3x 1.2x
VTR Unlock Forecast - 30 Days FREE Trial $37556M 168.0x 3.0x
WELL Unlock Forecast - 30 Days FREE Trial $134701M 103.7x 3.5x
WHLR Unlock Forecast - 30 Days FREE Trial $2M 1.7x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $33M 17.5x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $88M 56.0x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $3M 2.0x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $14496M 44.1x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $678M 18.5x 1.5x
WY Unlock Forecast - 30 Days FREE Trial $15390M 62.3x 1.6x

Frequently Asked Questions - CENTERSPACE Stock Forecast

How accurate are CENTERSPACE stock predictions?

Our AI model shows a 23% Spearman correlation coefficient for CSR predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence CENTERSPACE stock price forecasts?

Our analysis considers CENTERSPACE's financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is CENTERSPACE a good investment in 2025?

Based on our AI analysis, CENTERSPACE shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are CENTERSPACE forecasts updated?

CENTERSPACE stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced CENTERSPACE Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for CENTERSPACE stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...